| The free radical in pyruvate formate-lyase is located on glycine-734. AF Wagner, M Frey, FA Neugebauer, W Schäfer, J Knappe Proceedings of the National Academy of Sciences 89 (3), 996-1000, 1992 | 483 | 1992 |
| Adenosylmethionine-dependent synthesis of the glycyl radical in pyruvate formate-lyase by abstraction of the glycine C-2 pro-S hydrogen atom. Studies of [2H] glycine … M Frey, M Rothe, AF Wagner, J Knappe Journal of Biological Chemistry 269 (17), 12432-12437, 1994 | 212 | 1994 |
| Pyruvate formate-lyase mechanism involving the protein-based glycyl radical J Knappe, S Elbert, M Frey, AFV Wagner Biochemical Society Transactions 21 (3), 731-734, 1993 | 111 | 1993 |
| Detection of histidine-tagged fusion proteins by using a high-specific mouse monoclonal anti-histidine tag antibody. H Zentgraf, M Frey, S Schwinn, C Tessmer, B Willemann, Y Samstag, ... Nucleic acids research 23 (16), 3347, 1995 | 55 | 1995 |
| Purification of the human apical conjugate export pump MRP2: Reconstitution and functional characterization as substrate‐stimulated ATPase W Hagmann, AT Nies, J König, M Frey, H Zentgraf, D Keppler European journal of biochemistry 265 (1), 281-289, 1999 | 53 | 1999 |
| Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass FD Vogl, M Frey, R Kreienberg, IB Runnebaum British Journal of Cancer 83 (10), 1338-1343, 2000 | 50 | 2000 |
| Mechanistic insights into p53-promoted RNA-RNA annealing W Nedbal, M Frey, B Willemann, H Zentgraf, G Sczakiel Journal of molecular biology 266 (4), 677-687, 1997 | 44 | 1997 |
| Biological effect and chemical monitoring of Watch List substances in European surface waters: steroidal estrogens and diclofenac–effect-based methods for monitoring frameworks E Simon, A Duffek, C Stahl, M Frey, M Scheurer, J Tuerk, L Gehrmann, ... Environment International 159, 107033, 2022 | 41 | 2022 |
| p53 autoantibodies in patients with autoimmune diseases: a quantitative approach HM Kuhn, A Kromminga, HT Flammann, M Frey, P Layer, R Arndt Autoimmunity 31 (4), 229-235, 1999 | 35 | 1999 |
| Anti-p53 in breast cancer: concordance of different assay procedures and association with p53 antigen expression M Volkmann, HP Sinn, D Gaugel, M Frey, Y Hajjar, J Ludwig, S Hänsel, ... Oncology 63 (3), 297-305, 2002 | 26 | 2002 |
| Two novel real time cell-based assays quantify beta-blocker and NSAID specific effects in effluents of municipal wastewater treatment plants K Bernhard, C Stahl, R Martens, HR Köhler, R Triebskorn, M Scheurer, ... Water research 115, 74-83, 2017 | 19 | 2017 |
| Intrinsic presence of poly (ADP-ribose) is significantly increased in malignant prostate compared to benign prostate cell lines. T McNealy, M Frey, L Trojan, T Knoll, P Alken, MS Michel Anticancer research 23 (2B), 1473-1478, 2003 | 19 | 2003 |
| p53-autoantibody may be more sensitive than CA-125 in monitoring microscopic and macroscopic residual disease after primary therapy for epithelial ovarian cancer N Häfner, K Nicolaus, S Weiss, M Frey, H Diebolder, M Rengsberger, ... Journal of cancer research and clinical oncology 139, 1207-1210, 2013 | 16 | 2013 |
| Monitoring primary effects of pharmaceuticals in the aquatic environment with mode of action-specific in vitro biotests R Triebskorn, K Berg, I Ebert, M Frey, D Jungmann, J Oehlmann, ... Environmental science & technology 49 (5), 2594-2595, 2015 | 14 | 2015 |
| Detection of serum autoantibodies to tumor suppressor gene p53 with a new enzyme-linked immunosorbent assay in patients with ovarian cancer. D Marx, M Frey, H Zentgraf, G Adelssen, A Schauer, W Kuhn, H Meden Cancer Detection and Prevention 25 (2), 117-122, 2001 | 10 | 2001 |
| Scha «fer, W. and Knappe, J.(1992) Proc AF Wagner, M Frey, FA Neugebauer Natl. Acad. Sci. USA 89, 996-1000, 0 | 8 | |
| Up-regulation of two distinct p53-DNA binding functions by covalent poly (ADP-ribosyl) ation: transactivating and single strand break sensing R Alvarez-Gonzalez, H Mendoza-Alvarez, M Frey, H Zentgraf Cancer investigation 31 (9), 563-570, 2013 | 7 | 2013 |
| Antibodies active against a fusion polypeptide comprising a histidine portion H Zentgraf, C Tessmer, I Velhagen, S Schwinn, M Frey US Patent 6,790,940, 2004 | 6 | 2004 |
| Process for detecting specific antibodies acting against HPV proteins H Zentgraf, M Frey, I Velhagen, R Martens, W Meschede, M Pawlita, ... US Patent 6,214,541, 2001 | 6 | 2001 |
| Functional interactions of PARP-1 with p53 R Alvarez-Gonzalez, H Zentgraf, M Frey, H Mendoza-Alvarez Poly (ADP-ribosyl) ation, 61-66, 2006 | 5* | 2006 |
